Results 141 to 150 of about 80,065 (281)

Marine Compound Xyloketal B as a Potential Drug Development Target for Neuroprotection [PDF]

, 2018
Haifan Gong, Zhengwei Luo, Wenliang Chen, Zhong‐Ping Feng, Guan‐Lei Wang, Hong‐Shuo Sun   +5 more
openalex   +1 more source

Toxicity profile analysis of compound 6e insights from ADMET “SAR” predictions for safer drug development.

Yasser Hussein Issa Mohammed (17140711), Ahmed Hassen Shntaif (22320292), Saad Alghamdi (362506), Ahd A. Mansour (21660692), Naeem F. Qusty (15416890), Azhar S. Sindi (13259916), Ahmad O. Babalghith (15279713), Ghazi A. Bamagous (22320295), Eman Adnan Abu-Seer (22320298)   +8 more
openalex   +1 more source

Unveiling the Potential of Dombeya buettneri K.Schum As a Drug Agent: Molecular Docking of Compounds With Enzymes Linked to Diabetes and Neurodegenerative Disease [PDF]

Esther E. Nwanna, Esther E. Nwanna, Samuel Chima Ugbaja, Awais Ali, Augustina Oduje Akinsanmi, Onyekachi Paschal Ezeoru, Fisayo Eunice Adeyeye, Hezekiel M. Kumalo, Emmanuel Okello   +8 more
openalex   +1 more source

Outsourcing Animal Drug Compounding [PDF]

, 2020
openaire   +1 more source

2D interaction of compound 6e (left) and indomethacin drug (right) within the active site of cyclooxygenase-1 (COX-1) (PDB ID: 1EQG).

Yasser Hussein Issa Mohammed (17140711), Ahmed Hassen Shntaif (22320292), Saad Alghamdi (362506), Ahd A. Mansour (21660692), Naeem F. Qusty (15416890), Azhar S. Sindi (13259916), Ahmad O. Babalghith (15279713), Ghazi A. Bamagous (22320295), Eman Adnan Abu-Seer (22320298)   +8 more
openalex   +1 more source

Extemporaneous Formulations for Pediatric Patients: Global Necessities, Challenges and Opportunities. [PDF]

Pharmaceutics
Pai VB, Nahata MC.
europepmc   +1 more source

The Drug Quality and Security Act of 2013: Compounding Consistently [PDF]

, 2017
Kim, Stella Haeyoung
core   +1 more source

Improving Compound Selection in Drug Discovery: A Quantitative Approach for Biased Data Modelling

Shema Shirley Mamachen
openalex   +2 more sources

Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas’ disease drug discovery

, 2018
Lorna MacLean, John Thomas, Michael D. Lewis, Ignacio Cotillo, David W. Gray, Manu De Rycker   +5 more
openalex   +2 more sources

In Silico Identification of Escherichia coli Curli Protein Phytochemical Inhibitors as Potential Antibiotic Drug Compounds for Urinary Tract Infection via Molecular Docking

Den Marc Panes Exala, Earl Adriane Cano, Angela Nole Shayenne Tano Coderos, Danielle Cruz, Samson Pan Decasa, Juliana Carlidy Llena Elauria, Jalen Rose Panaligan Esguerra, A. Ferrer   +7 more
openalex   +1 more source